Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, OrganoClick AB's Enterprise Value is kr156.43 Mil.
OrganoClick AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was kr-29.14 Mil. Therefore, OrganoClick AB's EV-to-EBIT ratio for today is -5.37.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, OrganoClick AB's Enterprise Value is kr156.43 Mil.
OrganoClick AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-10.88 Mil. Therefore, OrganoClick AB's EV-to-EBITDA ratio for today is -14.37.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, OrganoClick AB's Enterprise Value is kr156.43 Mil.
OrganoClick AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was kr98.16 Mil. Therefore, OrganoClick AB's EV-to-Revenue ratio for today is 1.59.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, OrganoClick AB's Enterprise Value is kr156.43 Mil.
OrganoClick AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr-8.61 Mil. Therefore, OrganoClick AB's EV-to-FCF ratio for today is -18.17.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
OrganoClick AB (OSTO:ORGC) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
OrganoClick AB's current Enterprise Value is kr156.43 Mil.
OrganoClick AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-29.14 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
OrganoClick AB's current Enterprise Value is kr156.43 Mil.
OrganoClick AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-10.88 Mil.
OrganoClick AB's current Enterprise Value is kr156.43 Mil.
OrganoClick AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr98.16 Mil.
OrganoClick AB's current Enterprise Value is kr156.43 Mil.
OrganoClick AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.78 Mil.
OrganoClick AB's current Enterprise Value is kr156.43 Mil.
OrganoClick AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-8.61 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrganoClick AB Enterprise Value Related Terms
OrganoClick AB Enterprise Value Historical Data
* Premium members only.
The historical data trend for OrganoClick AB's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ORGC vs LIN, SHW, ECL: Enterprise Value Comparison
For the Specialty Chemicals subindustry, OrganoClick AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrganoClick AB Enterprise Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, OrganoClick AB's Enterprise Value distribution charts can be found below:
* The bar in red indicates where OrganoClick AB's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
OrganoClick AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of kr156.43 Mil mean?
OrganoClick AB (OSTO:ORGC) has a Enterprise Value of kr156.43 Mil as of Jul. 16, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on OrganoClick AB and its competitors.
Is OrganoClick AB's Enterprise Value too high?
OrganoClick AB's current Enterprise Value is kr156.43 Mil. Overall, OrganoClick AB has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's Enterprise Value compare to LIN and SHW?
OrganoClick AB's Enterprise Value of kr156.43 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Chemicals company?
A good Enterprise Value depends on the Chemicals industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on OrganoClick AB and its competitors. OrganoClick AB's current Enterprise Value is kr156.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
Based on GuruFocus' analysis, OrganoClick AB (OSTO:ORGC) is currently considered Possible Value Trap. The stock's GF Value™ is kr1.99, compared to a current price of kr0.42 — trading 78.8% below its estimated fair value. The current Enterprise Value is kr156.43 Mil. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For OrganoClick AB (OSTO:ORGC), the current Enterprise Value is kr156.43 Mil as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrganoClick AB (OSTO:ORGC) Overvalued in 2026?
Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued.
The current stock price of kr0.42 is trading 78.8% below its estimated GF Value™ of kr1.99.
GuruFocus considers OrganoClick AB to be Possible Value Trap.
Key valuation signals for OSTO:ORGC:
Enterprise Value: kr156.43 Mil
GF Value™: kr1.99 vs. price of kr0.42 (78.8% below fair value)
No single metric tells the full story. See the OSTO:ORGC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score
Get the complete analysis for OSTO:ORGC
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ORGC has been successfully added to your 
